patient engagement

Patients

Patient centricity and the changing pharmaceutical vista

Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds.

Oncology

Economist Impact: World Cancer Series – pharmaphorum in atte...

To conclude pharmaphorum’s look back at day one of The Economist’s 8th Annual World Cancer Series congress in Brussels, Belgium, in November – where the foci were “innovation, equity, and e

Sales & Marketing

Next generation patient engagement and enriched insights

Increasing Confidence in Person-Generated Health Data (PGHD) and its Impact on Clinical Decision Making

Views & Analysis

Key operational considerations to optimise decentralised cli...

Now that the COVID-19 pandemic has provided the industry with a solid foundation of experience with decentralised trials, it is appropriate to reflect and ask whether DCT studies are truly

Events

Reuters Pharma 2022 - a day one overview - part 1

The Reuters Pharma event 2022 began as a bustling industry affair yesterday, based out of the Nice Acropolis convention centre on France’s balmy south coast.

Views & Analysis